UNSPSC 51422413: Flunisolide

This classification denotes a therapeutic glucocorticoid with the molecular formula 2C24H31FO6.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, QK4DYS664X chemically known as 6.alpha.-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone, hemihydrate but generally known as flunisolide, which bears US NIH Compound Identifier 53655. European Medicines Agency schedules Flunisolide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07709MIG.

UNSPSC 51422413 Flunisolide, a Commodity code, nominally refers to a specific corticosteroid medication, but recent state and local opportunities tagged under this code show a mismatch between the code's abstract pharmaceutical scope and the work actually being solicited. The Seminole County, Florida IFB (IFB60459723LAS, posted June 30, 2026, due July 26, 2023) procures naloxone and drug deactivation systems for community health initiatives, with 1,900 units of naloxone and 800 safe drug deactivation systems annually delivered quarterly to the Seminole County Community Health Building. The Texas Health and Human Services Commission's RFI (HHS0017013, posted April 3, 2026) solicits vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information about vendors' capacity to establish direct relationships between state pharmacy benefit programs and pharmaceutical manufacturers. Neither opportunity directly addresses flunisolide procurement, suggesting the code assignment does not reflect the medications or services being actively purchased under this taxonomy entry in recent state and local posting activity.

Recent activity under this code comes primarily from Florida and Texas. The Seminole County opportunity represents county-level public health procurement, while the Texas HHS Commission RFI reflects state-level health and human services contracting at the exploratory stage. The Seminole County IFB specifies a two-year initial term with one-year renewal option, E-Verify compliance, workers' compensation and general liability insurance requirements, and a three-month probationary period with potential FEMA funding subject to federal environmental compliance. The Texas RFI remains in information-gathering phase, with no formal evaluation criteria, site visits, or award values specified at this stage. This code shows little relevant recent activity aligned with its nominal pharmaceutical scope.